Patients with advanced , unresectable NETs of pancreatic , gastrointestinal foregut or unknown primary site were randomised to receive three-weekly capecitabine ( Cap ) @ mg/m ( @ ) twice daily orally , streptozocin ( Strep ) @ g/m ( @ ) intravenously on day @ , with or without cisplatin ( Cis ) @ mg/m ( @ ) intravenously on day @ .